XML 66 R51.htm IDEA: XBRL DOCUMENT v3.23.4
COMMITMENTS AND CONTINGENCIES (Details Narrative)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
Aug. 22, 2023
USD ($)
May 16, 2023
Mar. 02, 2023
ILS (₪)
Oct. 06, 2022
USD ($)
Oct. 06, 2022
USD ($)
Oct. 03, 2022
USD ($)
Mar. 31, 2021
USD ($)
Mar. 31, 2021
USD ($)
Feb. 04, 2020
USD ($)
Apr. 28, 2019
USD ($)
Apr. 28, 2019
USD ($)
May 25, 2018
USD ($)
shares
Jan. 04, 2018
USD ($)
$ / shares
Jan. 04, 2018
USD ($)
$ / shares
shares
Jan. 04, 2018
ILS (₪)
shares
Jan. 04, 2018
USD ($)
$ / shares
Jan. 04, 2018
ILS (₪)
Jun. 30, 2012
Jun. 30, 2023
USD ($)
[1]
Mar. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Nov. 01, 2023
USD ($)
Nov. 01, 2023
ILS (₪)
Sep. 30, 2023
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                                                      
Stock issued during period, value, new issues                                       $ 6,558,000   $ 4,324,000        
Net loss on trading of common stock                   $ 151,000                                  
Gross proceeds from cash fee percentage     7.00%                                                
Gross proceeds from management fee percentage     1.00%                                                
Joseph Mona [Member]                                                      
Loss Contingencies [Line Items]                                                      
Purchase price of plaintiffs   $ 485,000           $ 485,000 $ 485,000                                    
Device [Member]                                                      
Loss Contingencies [Line Items]                                                      
Royalties percentage         3.00% 3.00%                                          
Integrated Product [Member]                                                      
Loss Contingencies [Line Items]                                                      
Royalties percentage         1.50% 1.50%                                          
Securities Purchase Agreement [Member]                                                      
Loss Contingencies [Line Items]                                                      
Purchase price of plaintiffs                                           $ 6,750,000 $ 6,750,000        
Israeli Innovation Authority [Member]                                                      
Loss Contingencies [Line Items]                                                      
Currency exchange rate, description exchange rate on September 30, 2023 of NIS 1.00 = $0.2614, would be approximately $423     exchange rate on such date of NIS 1.00 = $0.27457, would be approximately $82                                              
Grants receivable $ 156,000     ₪ 300,000,000                                   $ 156,000       ₪ 1,620,000  
Israeli Innovation Authority [Member] | Subsequent Event [Member]                                                      
Loss Contingencies [Line Items]                                                      
Grants receivable                                               $ 27 ₪ 109,474    
Israeli Innovation Authority [Member] | Minimum [Member]                                                      
Loss Contingencies [Line Items]                                                      
Royalties payable as percentage of future sales       3.00%                                   3.00% 3.00%        
Israeli Innovation Authority [Member] | Maximum [Member]                                                      
Loss Contingencies [Line Items]                                                      
Royalties payable as percentage of future sales       5.00%                                   5.00% 3.50%        
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                                                      
Loss Contingencies [Line Items]                                                      
Repayment of government grants                           $ 530,000 $ 530,000                        
Israeli Innovation Authority [Member] | Nitiloop [Member]                                                      
Loss Contingencies [Line Items]                                                      
Repayment of government grants         $ 925,000 $ 925,000                                          
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                                                      
Loss Contingencies [Line Items]                                                      
Royalties payable as percentage of future sales                                     1.50%                
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                                                      
Loss Contingencies [Line Items]                                                      
Royalties payable as percentage of future sales                                     3.00%                
CardioSert Ltd [Member] | Technology [Member]                                                      
Loss Contingencies [Line Items]                                                      
Payment to acquire intangible assets                         $ 250,000   $ 300,000   $ 50,000                    
Number of common shares issued for acquisition | shares                         6,738   6,738 6,738                      
Number of common shares issued for acquisition, value                         $ 74,000   $ 74,000                        
Buy back amount per patent | $ / shares                           $ 1.00 $ 1.00   $ 1.00                    
Consulting fee description                             Additionally, the CardioSert Agreement may be terminated by either party upon breach of the other (subject to cure). Until May 2023, Microbot Israel paid CardioSert a monthly consultation fee of NIS40,000 (or approximately US$11, based on an exchange rate of NIS 3.7 to the dollar) covering up to 60 consulting hours per month, relating to the development of the Technology. Additionally, the CardioSert Agreement may be terminated by either party upon breach of the other (subject to cure). Until May 2023, Microbot Israel paid CardioSert a monthly consultation fee of NIS40,000 (or approximately US$11, based on an exchange rate of NIS 3.7 to the dollar) covering up to 60 consulting hours per month, relating to the development of the Technology. CardioSert agreed to assist Microbot Israel in the development of the Technology for a minimum of one year, for a monthly consultation fee of NIS40 (or approximately US$11.37, based on an exchange rate of NIS 3.519 to the dollar) covering up to 60 consulting hours per month CardioSert agreed to assist Microbot Israel in the development of the Technology for a minimum of one year, for a monthly consultation fee of NIS40 (or approximately US$11.37, based on an exchange rate of NIS 3.519 to the dollar) covering up to 60 consulting hours per month                  
Monthly consultation fee | ₪                               ₪ 40,000,000   ₪ 40,000                  
Monthly consultation fee in USD | $ / shares                             $ 11   $ 11.37                    
Currency exchange rate, description                             exchange rate of NIS 3.7 to the dollar exchange rate of NIS 3.7 to the dollar exchange rate of NIS 3.519 to the dollar exchange rate of NIS 3.519 to the dollar                  
CardioSert Ltd [Member] | Minimum [Member] | Technology [Member]                                                      
Loss Contingencies [Line Items]                                                      
Investments                           $ 2,000,000 $ 2,000,000   $ 2,000,000                    
H.C. Wainwright & Co. LLC [Member]                                                      
Loss Contingencies [Line Items]                                                      
Monthly consultation fee             $ 565,000                                        
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                                                      
Loss Contingencies [Line Items]                                                      
Offering costs                                                     $ 10,000,000
Stock issued during period, value, new issues         $ 8,000,000 $ 8,000,000                                          
Alliance Investment Management, Ltd. [Member]                                                      
Loss Contingencies [Line Items]                                                      
Litigation settlement                     $ 468,000 $ 468,000                              
Two Thousand Thirteen To June Thirty Two Thousand Twenty Two [Member] | Israeli Innovation Authority [Member]                                                      
Loss Contingencies [Line Items]                                                      
Total grants obtained                                             $ 1,500,000        
Two Thousand Thirteen To September Thirty Two Thousand Twenty Three [Member] | Israeli Innovation Authority [Member]                                                      
Loss Contingencies [Line Items]                                                      
Total grants obtained                                           $ 1,656,000          
[1] Net of issuance costs in the amount of $1,075.